Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Nasdaq/NYSE Compliance Notice

Every nasdaq/nyse compliance notice filing by a US-listed company that our alert engine sent, newest first.

5:01 PM ET 8-K
Nasdaq/NYSE Compliance Notice Propanc Biopharma, Inc. PPCB

Propanc Biopharma Nasdaq/NYSE Compliance Notice

Propanc Biopharma received a delisting notice from Nasdaq on October 23, 2026, for failing to maintain the $1.00 minimum bid price requirement. Because the company already completed a reverse stock split within the past year, it is ineligible for the standard 180-day grace period and faces delisting on November 2, 2026. The company intends to appeal the determination to a hearings panel, which will stay the delisting process.

Counterparty
Nasdaq
5:01 PM ET 8-K
Nasdaq/NYSE Compliance Notice Glucotrack, Inc. GCTK

Glucotrack Nasdaq/NYSE Compliance Notice

Glucotrack received notice from a Nasdaq Hearings Panel that its securities will be delisted after failing to maintain a $1.00 minimum bid price through the required exception period. Trading on Nasdaq will be suspended on October 30, 2026, and the company plans to transition its common stock to the OTC Markets Group (OTCID).

Counterparty
The Nasdaq Stock Market LLC
4:30 PM ET 8-K
Nasdaq/NYSE Compliance Notice Greenland Energy Co GLND

Greenland Energy Nasdaq/NYSE Compliance Notice

Greenland Energy Company received a deficiency notice from Nasdaq for failing to meet the majority independent director and audit committee requirements following the resignation of director Roderick McIllree. The company has already cured the audit committee deficiency by appointing Melanie Furlan to the committee and has until at least October 20, 2027, to regain compliance with the majority independent director rule.

Counterparty
Nasdaq
4:27 PM ET 8-K
Nasdaq/NYSE Compliance Notice Cullen/Frost Bankers, Inc. CFR

Cullen/Frost Bankers Nasdaq/NYSE Compliance Notice

Cullen/Frost Bankers, Inc. notified the NYSE of its intention to voluntarily withdraw its common stock and Series B preferred stock listings and transfer them to the Texas Stock Exchange (TXSE). The company expects to cease trading on the NYSE on November 11, 2026, and begin trading on the TXSE on November 12, 2026, under its existing ticker symbols.

Counterparty
Texas Stock Exchange
4:16 PM ET 8-K
Nasdaq/NYSE Compliance Notice CID Holdco, Inc. DAIC

CID Holdco Nasdaq/NYSE Compliance Notice

CID HoldCo, Inc. (Dot Ai) received a favorable decision from the Nasdaq Hearings Panel allowing the company to continue its listing on The Nasdaq Stock Market. The decision is subject to the company transferring its listing to The Nasdaq Capital Market by November 2, 2026, following the company's successful acquisition of Envoy Technologies and regained compliance with shareholders' equity requirements.

Counterparty
Nasdaq
5:00 PM ET 8-K
Nasdaq/NYSE Compliance Notice Milestone Pharmaceuticals Inc. MIST

Milestone Pharmaceuticals Nasdaq/NYSE Compliance Notice

Milestone Pharmaceuticals received a deficiency notice from Nasdaq on October 23, 2026, because its common shares failed to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company has until April 21, 2027, to regain compliance by having its shares close at $1.00 or higher for at least 10 consecutive business days.

Counterparty
Nasdaq
Term
180 days
4:31 PM ET 8-K
Nasdaq/NYSE Compliance Notice Eureka Acquisition Corp EURK

Eureka Acquisition Nasdaq/NYSE Compliance Notice

Eureka Acquisition Corp received a notification from Nasdaq granting the company an extension until January 31, 2027, to regain compliance with the Public Float Rule (Nasdaq Listing Rule 5450(a)(4)). The extension follows the company's submission of a compliance plan on October 12, 2026, after initially receiving a deficiency notice in August.

Counterparty
The Nasdaq Stock Market LLC
Term
through January 31, 2027
12:30 PM ET 8-K
Nasdaq/NYSE Compliance Notice Rain Enhancement Technologies Holdco, Inc. RAIN

Rain Enhancement Technologies Holdco Nasdaq/NYSE Compliance Notice

Rain Enhancement Technologies (RAIN) has been granted a continued listing extension by a Nasdaq Hearings Panel. The company must satisfy specific milestones related to its proposed business combination with Tensor Networks and meet all initial listing criteria by February 16, 2027, to avoid delisting.

Counterparty
Nasdaq
Term
through Feb 16, 2027
9:30 AM ET 8-K
Nasdaq/NYSE Compliance Notice OSR Health, Inc. OSRH

OSR Health Nasdaq/NYSE Compliance Notice

OSR Health received a written decision from the Nasdaq Hearings Panel on October 23, 2026, denying its request for continued listing and determining to delist the company's securities. The delisting follows the company's failure to regain compliance with the $1.00 minimum bid price requirement, and its securities will continue to be quoted on the over-the-counter market under the symbols OSRH and OSRHW.

Counterparty
The Nasdaq Stock Market LLC
4:59 PM ET 8-K
Nasdaq/NYSE Compliance Notice Socket Mobile, Inc. SCKT

Socket Mobile Nasdaq/NYSE Compliance Notice

Socket Mobile, Inc. has notified Nasdaq of its intention to voluntarily delist its common stock from The Nasdaq Capital Market and transition to the OTCID Market. The decision follows a deficiency notice received on August 24, 2026, regarding the company's failure to meet the minimum stockholders' equity requirement of $2.5 million. The company expects the delisting to be effective on or about November 19, 2026, to reduce administrative costs and regulatory overhead.

Counterparty
Nasdaq
4:33 PM ET 8-K
Nasdaq/NYSE Compliance Notice Nextnrg, Inc. NXXT

Nextnrg Nasdaq/NYSE Compliance Notice

NextNRG, Inc. received a deficiency notice from Nasdaq on October 21, 2026, for failing to maintain a minimum market value of listed securities (MVLS) of $35 million. The company also failed to meet alternative listing standards for stockholders' equity and net income, and has until April 19, 2027, to regain compliance.

Counterparty
Nasdaq
Term
180 days
4:00 PM ET 8-K
Nasdaq/NYSE Compliance Notice Advasa Holdings, Inc. ADBT

Advasa Holdings Nasdaq/NYSE Compliance Notice

Advasa Holdings received a deficiency notice from Nasdaq on October 21, 2026, because its common stock bid price fell below the $1.00 minimum requirement for 30 consecutive business days. The company has until April 19, 2027, to regain compliance by maintaining a minimum bid price of $1.00 for at least ten consecutive business days. If compliance is not met, the company may be eligible for an additional 180-day extension by transferring to the Nasdaq Capital Market.

Counterparty
Nasdaq
Term
180 days
12:16 PM ET 8-K
Nasdaq/NYSE Compliance Notice Rekor Systems, Inc. REKR

Rekor Systems Nasdaq/NYSE Compliance Notice

Rekor Systems received a 180-day extension from Nasdaq to regain compliance with the $1.00 minimum bid price requirement, providing the company until April 26, 2027, to meet the standard. To regain compliance, the company's common stock must maintain a closing bid price of at least $1.00 for ten consecutive business days. The notice has no immediate impact on the listing of the company's stock, which continues to trade under the symbol 'REKR'.

Counterparty
Nasdaq
Term
180 days
9:11 AM ET 8-K
Nasdaq/NYSE Compliance Notice Ip Strategy Holdings, Inc. IPST

Ip Strategy Holdings Nasdaq/NYSE Compliance Notice

IP Strategy Holdings, Inc. has regained compliance with Nasdaq Listing Rule 5250(c)(1) following the filing of its delayed Quarterly Report on Form 10-Q for the period ended June 30, 2026. Nasdaq had previously issued a deficiency notice on August 26, 2026, due to the late filing, but has now confirmed the matter is closed.

Counterparty
The Nasdaq Stock Market LLC
5:24 PM ET 8-K
Nasdaq/NYSE Compliance Notice Eve Holding, Inc. EVEX

Eve Holding Nasdaq/NYSE Compliance Notice

The New York Stock Exchange (NYSE) has commenced proceedings to delist Eve Holding's public warrants (EVEXW) and immediately suspended their trading due to abnormally low selling price levels. The company's common stock (EVEX) is unaffected by this action and will continue to trade on the NYSE.

Counterparty
New York Stock Exchange
5:00 PM ET 8-K
Nasdaq/NYSE Compliance Notice YHN Acquisition I Ltd YHNAF

YHN Acquisition I Nasdaq/NYSE Compliance Notice

YHN Acquisition I Limited received a Staff Determination notice from Nasdaq on October 21, 2026, stating that the company failed to regain compliance with minimum market value requirements for continued listing. The company's board has decided not to appeal the delisting or transfer to the Nasdaq Capital Market, and trading is expected to be suspended on October 30, 2026. The company intends to apply for quotation on the OTC Markets following the delisting.

Counterparty
The Nasdaq Stock Market LLC
4:57 PM ET 8-K
Nasdaq/NYSE Compliance Notice Zeo Energy Corp. ZEO

Zeo Energy Nasdaq/NYSE Compliance Notice

Zeo Energy Corp. received a 180-day extension from Nasdaq, until April 19, 2027, to regain compliance with the $1.00 minimum bid price requirement. The company's Class A common stock will continue to trade on the Nasdaq Capital Market during this period while management monitors the stock price and considers options to meet the listing standard.

Counterparty
Nasdaq
Term
180 days
4:16 PM ET 8-K
Nasdaq/NYSE Compliance Notice Azio AI Holdings, Inc. AZIO

Azio AI Holdings Nasdaq/NYSE Compliance Notice

Azio AI Holdings announced it has regained compliance with Nasdaq's minimum stockholders' equity requirement of $2.5 million. The company achieved this through a business combination with Azio AI Corporation, warrant exercises, and share issuances under a standby equity purchase agreement. Nasdaq will continue to monitor the company's compliance through its next periodic financial report.

Counterparty
The Nasdaq Stock Market LLC
6:02 AM ET 8-K
Nasdaq/NYSE Compliance Notice Elme Communities ELMES

Elme Communities Nasdaq/NYSE Compliance Notice

The New York Stock Exchange (NYSE) has commenced proceedings to delist Elme Communities' common shares and immediately suspended trading due to abnormally low selling price levels. The company does not intend to appeal the decision as it is already executing a previously approved Plan of Sale and Liquidation. Elme anticipates its shares will begin trading over-the-counter (OTC) under the symbol 'ELMES' on October 26, 2026.

Counterparty
New York Stock Exchange
6:01 AM ET 8-K
Nasdaq/NYSE Compliance Notice Charlton Aria Acquisition Corp CHAR

Charlton Aria Acquisition Nasdaq/NYSE Compliance Notice

Charlton Aria Acquisition Corp notified Nasdaq that it failed to satisfy audit committee independence requirements due to a compensatory payment made to a firm associated with director Kyoung Tak Kim. The company regained compliance on October 22, 2026, by removing Mr. Kim from the audit committee and appointing Wang Jo Cha as his replacement.

Counterparty
Nasdaq
5:30 PM ET 8-K
Nasdaq/NYSE Compliance Notice Innventure, Inc. INV

Innventure Nasdaq/NYSE Compliance Notice

Innventure, Inc. received a deficiency notice from Nasdaq on October 23, 2026, for failing to maintain a minimum bid price of $1.00 per share for 30 consecutive business days. The company has until April 21, 2027, to regain compliance by maintaining a $1.00 bid price for at least 10 consecutive business days. If compliance is not met, the company may be eligible for an additional 180-day period if it transfers its listing to the Nasdaq Capital Market.

Counterparty
Nasdaq
Term
180 days
5:15 PM ET 8-K
Nasdaq/NYSE Compliance Notice Medicus Pharma Ltd. MDCX

Medicus Pharma Nasdaq/NYSE Compliance Notice

Medicus Pharma Ltd. regained compliance with Nasdaq's $1.00 minimum bid price requirement after its common shares closed at or above $1.00 for ten consecutive business days. This compliance notice supersedes a delisting determination letter received on October 20, 2026, which had initially triggered a delisting process due to the company's failure to meet the bid price and stockholders' equity requirements.

Counterparty
Nasdaq
4:53 PM ET 8-K
Nasdaq/NYSE Compliance Notice ARC Group Securities Acquisition I FJDI

ARC Group Securities Acquisition I Nasdaq/NYSE Compliance Notice

ARC Group Securities Acquisition I received a deficiency notice from Nasdaq because the aggregate market value of its outstanding warrants fell below the $1 million minimum requirement. The company has until December 4, 2026, to submit a plan to regain compliance, which could grant an extension until April 18, 2027. This notice currently only affects the listing of the warrants (FJDIW) and not the company's ordinary shares or units.

Counterparty
Nasdaq
Term
180 days
4:31 PM ET 8-K
Nasdaq/NYSE Compliance Notice Dragonfly Energy Holdings Corp. DFLI

Dragonfly Energy Holdings Nasdaq/NYSE Compliance Notice

Dragonfly Energy Holdings Corp. received an extension from Nasdaq until December 31, 2026, to regain compliance with the minimum stockholders' equity requirement of $2.5 million. The company had previously reported a stockholders' equity deficit of $184,000 for the period ended June 30, 2026. If the company fails to demonstrate compliance by the deadline, its common stock and warrants may be subject to delisting from The Nasdaq Capital Market.

Counterparty
Nasdaq
Term
through Dec 31, 2026
4:31 PM ET 8-K
Nasdaq/NYSE Compliance Notice Alaunos Therapeutics, Inc. TCRT

Alaunos Therapeutics Nasdaq/NYSE Compliance Notice

Alaunos Therapeutics has regained compliance with Nasdaq's minimum stockholders' equity requirement of $2,500,000 following a private placement financing. As a result, the previously scheduled delisting hearing has been cancelled and the company's common stock will continue to trade on The Nasdaq Capital Market.

Counterparty
Nasdaq
4:20 PM ET 8-K
Nasdaq/NYSE Compliance Notice Century Casinos Inc CNTY

Century Casinos Nasdaq/NYSE Compliance Notice

Century Casinos received a deficiency notice from Nasdaq because its Market Value of Listed Securities (MVLS) fell below the $35 million minimum requirement for 30 consecutive business days. The company has 180 calendar days, until April 19, 2027, to regain compliance by maintaining an MVLS of at least $35 million for 10 consecutive business days. The notice has no immediate effect on the listing of the company's common stock.

Counterparty
Nasdaq Stock Market LLC
Term
180 days
4:16 PM ET 8-K
Nasdaq/NYSE Compliance Notice Laser Photonics Corp LASE

Laser Photonics Nasdaq/NYSE Compliance Notice

Laser Photonics Corp received a deficiency notice from Nasdaq on October 20, 2026, for failing to maintain a minimum bid price of $1.00 per share for 30 consecutive business days. The company has 180 calendar days, until April 19, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for at least 10 consecutive business days.

Counterparty
Nasdaq
Term
180 days
4:10 PM ET 8-K
Nasdaq/NYSE Compliance Notice Citius Oncology, Inc. CTOR

Citius Oncology Nasdaq/NYSE Compliance Notice

Citius Oncology received a formal extension from Nasdaq until April 19, 2027, to regain compliance with the $1.00 minimum bid price requirement. To satisfy the rule, the company's common stock must close at or above $1.00 for at least ten consecutive business days. The stock continues to trade on the Nasdaq Capital Market under the symbol 'CTOR' while the company evaluates options to address the deficiency.

Counterparty
Nasdaq Stock Market LLC
Term
through April 19, 2027
4:07 PM ET 8-K
Nasdaq/NYSE Compliance Notice Stem, Inc. STEM

Stem Nasdaq/NYSE Compliance Notice

Stem, Inc. received a non-compliance letter from the NYSE because its average global market capitalization and stockholders' equity both fell below the $50 million minimum requirement over a 30 trading-day period. The company intends to submit a business plan within 45 days detailing how it will regain compliance within the 18-month cure period. The company's common stock will continue to trade on the NYSE during this period, subject to the exchange's acceptance of the plan.

Counterparty
New York Stock Exchange
Term
18 months
4:06 PM ET 8-K
Nasdaq/NYSE Compliance Notice Akebia Therapeutics, Inc. AKBA

Akebia Therapeutics Nasdaq/NYSE Compliance Notice

Akebia Therapeutics received a deficiency notice from Nasdaq because its common stock closed below the $1.00 minimum bid price for 30 consecutive business days. The company has until April 19, 2027, to regain compliance, which requires the stock to close at $1.00 or higher for at least 10 consecutive business days. Akebia is evaluating options to cure the deficiency, including a potential reverse stock split.

Counterparty
Nasdaq
Term
180 days

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.